[Mineral trioxide aggregate (MTA) a success story in apical surgery].

von Arx, Thomas (2016). [Mineral trioxide aggregate (MTA) a success story in apical surgery]. Swiss dental journal, 126(6), pp. 573-595. Schweizerische Zahnärzte-Gesellschaft SSO

[img] Text
SDJ_2016-06_praxis_D.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

The objective of apical surgery is to retain teeth with persistent apical pathosis following orthograde root canal treatment if endodontic non-surgical revision is difficult or associated with risks, or is even declined by the patient. Since the most frequent cause of recurrent apical disease is bacterial reinfection from the (remaining) root canal system, the bacteria-tight root-end filling is the most important step in apical surgery. In the early 1990s, mineral trioxide aggregate (MTA) was developed at the Loma Linda University in California/USA. Preclinical studies clearly showed that MTA has a high sealing capability, a good material stability and an excellent biocompatbility. Multiple experimental studies in animals highlighted the mild tissue reactions observed adjacent to this material. Furthermore, histological analysis of the periapical regions demonstrated a frequent deposition of new cementum not only onto the resection plane (cut dentinal surface), but also directly onto MTA. For these reasons, MTA is considered a bioactive material. In 1997 MTA was cleared for clinical use in patients. Multiple prospective clinical and randomized studies have documented high and constant success rates of MTA-treated teeth in apical surgery. A recently published longitudinal study showed that MTA-treated teeth remained stable over five years; hence the high healed rates documented after one year are maintained during long-term observation.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > School of Dental Medicine > Department of Oral Surgery and Stomatology

UniBE Contributor:

von Arx, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2296-6498

Publisher:

Schweizerische Zahnärzte-Gesellschaft SSO

Language:

German

Submitter:

Caroline Balz

Date Deposited:

23 Jul 2019 09:16

Last Modified:

05 Dec 2022 15:29

PubMed ID:

27377433

BORIS DOI:

10.7892/boris.131346

URI:

https://boris.unibe.ch/id/eprint/131346

Actions (login required)

Edit item Edit item
Provide Feedback